B-cell chronic lymphocytic leukemia (CLL), the most common blood cancer in the Western countries, is characterized by accumulation of neoplastic, small B lymphocytes expressing CD5, CD19 and CD23 in bone marrow, peripheral blood and other lymphoid tissues [1]. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.